Long-Acting Hydrogel-Based Depot Formulations of Tirzepatide and Semaglutide for the Management of Type 2 Diabetes and Weight

待确认 10 由 DDS 发布于 2026/3/22 10:35:54

DOI:10.1002/adtp.202500329
作者：Andrea I. d'Aquino, Changxin Dong, Leslee T. Nguyen, Jerry Yan, Carolyn K. Jons, Olivia M. Saouaf, Ye Eun Song, Noah Eckman, Sara Kapasi, Christian M. Will
文献类型：期刊论文
补充材料：只需要正文

Wiley

Abstract： Several incretin hormone therapies have been clinically approved and have revolutionized the treatment of diabetes and obesity. Promising therapeutics include semaglutide

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

20小时前

cuifang

5a29df4325c311f1bb8f34735aa3bc31.pdf

1天前

Book学术机器人

2026/3/22 10:35:54 未找到该文献，机器人已退出，请等待人工下载

2026/3/22 10:35:54 Book学术AI机器人收到请求，开始寻找文献

2026/3/22 10:35:54 已向机器人发送请求

1天前

DDS 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyStrategies to Enhance the Therapeutic Efficacy of GLP-1 Receptor Agonists through Structural Modification and Carrier Delivery